Back to Search
Start Over
Delaware Chancery Dismisses Claims In Viela Bio Merger Dispute
- Source :
- Mondaq Business Briefing. September 23, 2024
- Publication Year :
- 2024
-
Abstract
- In a significant decision that clarifies the standards for determining controlling stockholder status, the Delaware Court of Chancery dismissed claims against AstraZeneca and Viela Bio's directors in connection with Viela's [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Mondaq Business Briefing
- Publication Type :
- News
- Accession number :
- edsgcl.809628127